115 related articles for article (PubMed ID: 15238397)
1. Impact of ALLHAT on the role of angiotensin-converting enzyme inhibitors in the primary prevention of heart failure.
Ahmed A
Ann Intern Med; 2004 Jul; 141(1):W9; author reply W9a. PubMed ID: 15238397
[No Abstract] [Full Text] [Related]
2. Doxazosin and ALLHAT trial: a response.
Paran E
Am J Hypertens; 2002 Sep; 15(9):832. PubMed ID: 12219881
[No Abstract] [Full Text] [Related]
3. [ALLHAT Study: doxazosin arm is discontinued. Alpha blocker is less effective than a diuretic].
Einecke D
MMW Fortschr Med; 2000 Mar; 142(13):4-5. PubMed ID: 10783613
[No Abstract] [Full Text] [Related]
4. [Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists].
de Paz S; Martín AB; Iglesias A; Domínguez AR
Med Clin (Barc); 1999 Dec; 113(19):759. PubMed ID: 10680137
[No Abstract] [Full Text] [Related]
5. [Established blood pressure drug wins out in a comparative study. In hypertension, a diuretic first!].
Wepner U
MMW Fortschr Med; 2003 Jan; 145(1-2):10-2. PubMed ID: 12638431
[No Abstract] [Full Text] [Related]
6. Acute pancreatitis following lisinopril rechallenge.
Gershon T; Olshaker JS
Am J Emerg Med; 1998 Sep; 16(5):523-4. PubMed ID: 9725973
[TBL] [Abstract][Full Text] [Related]
7. [The ALLHAT study: contributions, limitations and prospectives].
Mancia G
Ital Heart J Suppl; 2003 Feb; 4(2):77-84. PubMed ID: 12762256
[No Abstract] [Full Text] [Related]
8. Can pemphigoid be provoked by lisinopril?
Kalińska-Bienias A; Rogoziński TT; Woźniak K; Kowalewski C
Br J Dermatol; 2006 Oct; 155(4):854-5. PubMed ID: 16965449
[No Abstract] [Full Text] [Related]
9. Lithium and antihypertensive medication: a potentially dangerous interaction.
Handler J
J Clin Hypertens (Greenwich); 2009 Dec; 11(12):738-42. PubMed ID: 20021532
[No Abstract] [Full Text] [Related]
10. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
11. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
[TBL] [Abstract][Full Text] [Related]
12. Lithium Toxicity from the Addition of an ACE Inhibitor with an Unexpected Type I Brugada Pattern ECG: Case Files of the Medical Toxicology Fellowship at the University of California, San Diego.
Schneir A; Masom CP
J Med Toxicol; 2020 Jul; 16(3):321-328. PubMed ID: 32297151
[No Abstract] [Full Text] [Related]
13. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.
Einhorn PT; Davis BR; Massie BM; Cushman WC; Piller LB; Simpson LM; Levy D; Nwachuku CE; Black HR;
Am Heart J; 2007 Jan; 153(1):42-53. PubMed ID: 17174636
[TBL] [Abstract][Full Text] [Related]
14. Possible causal role of lisinopril in a case of Kaposi's sarcoma.
Bilen N; Bayramgürler D; Aydeniz B; Apaydin R; Ozkara SK
Br J Dermatol; 2002 Nov; 147(5):1042-4. PubMed ID: 12410735
[No Abstract] [Full Text] [Related]
15. Ask the doctor. I have had heart failure since my heart attack a year ago. My physician initially prescribed lisinopril, an angiotensin-converting enzyme (ACE) inhibitor. Unfortunately, I was one of the unlucky people who got a cough with this drug that was so annoying I had to stop taking it. Now my doctor wants me to try a newer drug called valsartan. Is it likely to help me?
Lee TH
Harv Heart Lett; 2002 Jul; 12(11):8. PubMed ID: 12138046
[No Abstract] [Full Text] [Related]
16. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
17. [Renal side effects of angiotensin converting enzyme inhibitors].
Schmidt A; Mayer G
Wien Med Wochenschr; 1996; 146(16):454-6. PubMed ID: 9036683
[TBL] [Abstract][Full Text] [Related]
18. Lisinopril and Kaposi's sarcoma.
Di Carlo A
Br J Dermatol; 2004 Jan; 150(1):158-9; author reply 159. PubMed ID: 14746638
[No Abstract] [Full Text] [Related]
19. Hypertensive crisis after discontinuation of angiotensin-converting enzyme inhibitor.
McAlister FA; Lewanczuk R
Lancet; 1994 Nov; 344(8935):1502. PubMed ID: 7968134
[No Abstract] [Full Text] [Related]
20. Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Barzilay JI; Jones CL; Davis BR; Basile JN; Goff DC; Ciocon JO; Sweeney ME; Randall OS;
Diabetes Care; 2001 Apr; 24(4):654-8. PubMed ID: 11315826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
